(Q37062867)

18 August 2017

1 reference

title

Wnt signaling control of bone cell apoptosis (English)

1 reference

18 August 2017

0 references

Peter V N Bodine

1

1 reference

18 August 2017

publication date

1 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

18

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

248-253

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2008.13

18 August 2017

exact match

0 references

cites work

Mechanisms of Wnt signaling in development

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Wnt signalling: a theme with nuclear variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

The JNK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Wnt signalling: antagonistic Dickkopfs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Secreted Frizzled-related proteins: searching for relationships and patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Secreted antagonists of the Wnt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Wnt signalling pathway: a new target for the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

SARPs: a family of secreted apoptosis-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Secreted frizzled-related protein 1 (SFRP1) protects fibroblasts from ceramide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Bone resorption by osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Runx2/Cbfa1: A Multifunctional Regulator of Bone Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Runx2, a multifunctional transcription factor in skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

LRP5 and Wnt signaling: a union made for bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

High bone mass in mice expressing a mutant LRP5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

Signal transduction: A new canon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

inferred from DOI database lookup

7 January 2021

based on heuristic

Tissue culture models for studies of hormone and vitamin action in bone cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

inferred from DOI database lookup

7 January 2021

based on heuristic

Regulation of bone formation and vision by LRP5

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.13

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CR.2008.13

1 reference

18 August 2017

1 reference